![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 33/00 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 3475282 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17731149.5 |
Europos patento paraiškos padavimo data | 2017-06-20 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-05-01 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-09 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2017/064994 |
Data | 2017-06-20 |
(87) | Numeris | WO 2017/220517 |
Data | 2017-12-28 |
(30) | Numeris | Data | Šalis |
16175924 | 2016-06-23 | EP |
(72) |
GOBBI, Luca , CH
GRETHER, Uwe , CH
GUBA, Wolfgang , CH
KRETZ, Julian , CH
MARTIN, Rainer E. , CH
WESTPHAL, Matthias Valentin , CH
IJZERMAN, Adriaan Pieter , NL
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR |
[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR |